Press release EMA tightens rules on 147revolving door148for committee members and expertsIntention to take up job in pharma industry will trigger immediate halt of involvement in medicines evalu ID: 445139
Download Pdf The PPT/PDF document "May 2015EMA/282052/2015Press Office" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
May 2015EMA/282052/2015Press Office Press release EMA tightens rules on “revolving door”for committee members and expertsIntention to take up job in pharma industry will trigger immediate halt of involvement in medicines evaluation new guidance document . EMA’s policy on handling declarations of interestIn March 2014, the EMA management board endorsed major revision of EMA’s policy on handling declarations ofinterestfor scientific committee members and expertsThe revision tookinto account 30 Churchill PlaceCanary Wharf London E14 5EUUnited Kingdo Telephone+44 (0)20 3660Facsimile+44 (0)20 3660mailpress@ema.europa.euWebsitewww.ema.europa.eu Notes This press release, together with all related documents, is available on the Agency's webs European Medicines Agency policy on the handling of declarations of interests of scientific committees’ members and experts . European Medicines Agency breach of trust procedure on conflicts of interests for scientific committee members and experts . Procedural guidance on inclusion of declared interests in the European Medicines Agency’s electronic declaration of interests form (for scientific committees’ members and experts) . Guidance on the handling of declarations of interests in case of a scientific committee member/other (scientific) forum member’s intention to become an employee in a pharmaceutical company . More information on the work of the European Medicines Agency can be found on its website: www.ema.europa.eu ontact our press officer Monika BenstetterTel. +44 (0)20 8427mail: press@ema.europa.eu EMA tightens rules on “revolving door” for committee members and expertsEMA/282052/2015Page